Multicentre study shows regional heterogeneity in drug resistance of MRSA in Xinjiang, indicating the need for clinical surveillance.
MRSA epidemic strains in Xinjiang exhibit significant regional heterogeneity in molecular typing, resistance, and virulence profiles. Attention should be paid to the drug resistance of MRSA in different regions, while enhanced clinical surveillance is warranted for the unique spa type evolution within the ST22 lineage, particularly the highly virulent and multidrug-resistant ST22-t005-IV clone.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: